Arvee Laboratories (India) Ltd
Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Installed Capacity MT ・Standalone data |
|
|||||||
| Production Volume MT ・Standalone data |
||||||||
| Sales Volume MT ・Standalone data |
||||||||
| Capacity Utilization % ・Standalone data |
||||||||
| Employee Count Number ・Standalone data |
||||||||
| Product Count (SKUs) Number ・Standalone data |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Outcome of Board Meeting
19 May 2026 - Arvee Laboratories reported FY26 audited results: revenue Rs 3,151.41 lakh, profit Rs 252.63 lakh, unmodified opinion.
-
Price movement
15 April 2026 - Responds to NSE price-movement query; company states no material events.
-
Price movement
13 April 2026 - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …
-
Trading Window
27 March 2026 - Trading window closed from April 1, 2026 until two working days after results for period ended March 31, 2026.
-
Price movement
6 March 2026 - 24-Dec-2025 response to NSE: company compliant, no material events; cannot explain share price movement.
Product Profile:
a) Polymer Modifiers:[1]
Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt, 5-Sodiosulfo-Bis-(β-Hydroxyethyl)-Isophthalate
b) Contrast Media Intermediates:[2]
5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic
acid, 5-Aminoisophthalic acid, Dimethyl
5-Aminoisophthalate, 3,5-Dinitrobenzoic
Acid, 3,5-Diamino Benzoic Acid
c) Drug Intermediates:[3]
2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, Amino Pyridine,
Chloro Nitrobenzoic Acid